Self.made billionaire Sean Parker continues his vision on advancing medical researches. His Parker Institute for Cancer Immunotherapy collaborated with the Cancer Research Institute in an effort to use algorith in uncovering neoantigens.
immunotherapy
Breaking News
- IBM's Acquisition of HashiCorp for $6.4 Billion Confirmed, Aimed at Strengthening Cloud Capabilities
- Apple's Vision Pro Production Slashed as Demand Falls Short: Report
- TikTok Voluntarily Suspends New App's Task and Reward Program After EU Regulators Express Concern Over Addictive Effects Among Young Users
Bristol-Myers Squibb Co on Thursday filed a lawsuit against Merck & Co Inc for allegedly infringing its immunotherapy patent. The company is seeking unspecified damages.
Switzerland-based drug manufacturer Novartis will be buying closely-held Massachusetts-based biotechnology firm so it will grow its range of immunotherapeutics products to treat cancer, Bloomberg reported.
Subscribe to VCpost newsletter
Most Popular
- Doctors Raise Concerns Over Proposed Capital Gains Tax Changes
- Illinois Woman, Who Mysteriously Drowned After Giving $1.5 Million to Online Romance Scammers, Knew She'd 'End up Dead'
- Celebrity Designer Nancy Gonzalez Jailed for Smuggling Crocodile, Python Handbags
- Apple's Vision Pro Production Slashed as Demand Falls Short: Report
- FAA Investigates Boeing’s Alleged Retaliation Against 2 Engineers Who Conveyed Safety Concerns in 2022
- Kroger and Albertsons to Sell off 166 Stores in Effort to Gain Approval for Their $25 Billion Merger
- Russia's Surprising Economic Strength to Last Another 18 Months Despite Western Sanctions and Ukraine War, Think Tank Says
- China Shows Heavy Support for Hong Kong Economy After Pressuring the Country to Enact New Security Law
